163 related articles for article (PubMed ID: 21393580)
1. Pyripyropene A, an acyl-coenzyme A:cholesterol acyltransferase 2-selective inhibitor, attenuates hypercholesterolemia and atherosclerosis in murine models of hyperlipidemia.
Ohshiro T; Matsuda D; Sakai K; Degirolamo C; Yagyu H; Rudel LL; Omura S; Ishibashi S; Tomoda H
Arterioscler Thromb Vasc Biol; 2011 May; 31(5):1108-15. PubMed ID: 21393580
[TBL] [Abstract][Full Text] [Related]
2. New pyripyropene A derivatives, highly SOAT2-selective inhibitors, improve hypercholesterolemia and atherosclerosis in atherogenic mouse models.
Ohshiro T; Ohtawa M; Nagamitsu T; Matsuda D; Yagyu H; Davis MA; Rudel LL; Ishibashi S; Tomoda H
J Pharmacol Exp Ther; 2015 Nov; 355(2):299-307. PubMed ID: 26338984
[TBL] [Abstract][Full Text] [Related]
3. Selectivity of pyripyropene derivatives in inhibition toward acyl-CoA:cholesterol acyltransferase 2 isozyme.
Ohshiro T; Ohte S; Matsuda D; Ohtawa M; Nagamitsu T; Sunazuka T; Harigaya Y; Rudel LL; Omura S; Tomoda H
J Antibiot (Tokyo); 2008 Aug; 61(8):503-8. PubMed ID: 18997389
[TBL] [Abstract][Full Text] [Related]
4. Acyl-coenzyme A:cholesterol acyltransferase inhibitors for controlling hypercholesterolemia and atherosclerosis.
Miyazaki A; Sakai M; Sakamoto Y; Horiuchi S
Curr Opin Investig Drugs; 2003 Sep; 4(9):1095-9. PubMed ID: 14582454
[TBL] [Abstract][Full Text] [Related]
5. Synthesis and structure-activity relationship of pyripyropene A derivatives as potent and selective acyl-CoA:cholesterol acyltransferase 2 (ACAT2) inhibitors: part 3.
Ohtawa M; Yamazaki H; Ohte S; Matsuda D; Ohshiro T; Rudel LL; Ōmura S; Tomoda H; Nagamitsu T
Bioorg Med Chem Lett; 2013 Jul; 23(13):3798-801. PubMed ID: 23711919
[TBL] [Abstract][Full Text] [Related]
6. Synthesis and structure-activity relationship of pyripyropene A derivatives as potent and selective acyl-CoA:cholesterol acyltransferase 2 (ACAT2) inhibitors: part 1.
Ohtawa M; Yamazaki H; Ohte S; Matsuda D; Ohshiro T; Rudel LL; Omura S; Tomoda H; Nagamitsu T
Bioorg Med Chem Lett; 2013 Mar; 23(5):1285-7. PubMed ID: 23369538
[TBL] [Abstract][Full Text] [Related]
7. Penicillium griseofulvum F1959, high-production strain of pyripyropene a, specific inhibitor of acyl-CoA: cholesterol acyltransferase 2.
Choi JH; Rho MC; Lee SW; Choi JN; Lee HJ; Bae KS; Kim K; Kim YK
J Microbiol Biotechnol; 2008 Oct; 18(10):1663-5. PubMed ID: 18955816
[TBL] [Abstract][Full Text] [Related]
8. Design and synthesis of simple, yet potent and selective non-ring-A pyripyropene A-based inhibitors of acyl-coenzyme A: cholesterol acyltransferase 2 (ACAT2).
Zhan Y; Zhang XW; Xiong Y; Li BL; Nan FJ
Org Biomol Chem; 2016 Jan; 14(2):747-751. PubMed ID: 26584338
[TBL] [Abstract][Full Text] [Related]
9. Direct effect of an acyl-CoA:cholesterol acyltransferase inhibitor, F-1394, on atherosclerosis in apolipoprotein E and low density lipoprotein receptor double knockout mice.
Chiwata T; Aragane K; Fujinami K; Kojima K; Ishibashi S; Yamada N; Kusunoki J
Br J Pharmacol; 2001 Aug; 133(7):1005-12. PubMed ID: 11487509
[TBL] [Abstract][Full Text] [Related]
10. Pharmacological profile of SMP-797, a novel acyl-coenzyme a: cholesterol acyltransferase inhibitor with inducible effect on the expression of low-density lipoprotein receptor.
Ioriya K; Kino K; Horisawa S; Nishimura T; Muraoka M; Noguchi T; Ohashi N
J Cardiovasc Pharmacol; 2006 Feb; 47(2):322-9. PubMed ID: 16495773
[TBL] [Abstract][Full Text] [Related]
11. The lipid-laden foam cell: an elusive target for therapeutic intervention.
Brewer HB
J Clin Invest; 2000 Mar; 105(6):703-5. PubMed ID: 10727436
[No Abstract] [Full Text] [Related]
12. Selectivity of microbial acyl-CoA: cholesterol acyltransferase inhibitors toward isozymes.
Ohshiro T; Rudel LL; Omura S; Tomoda H
J Antibiot (Tokyo); 2007 Jan; 60(1):43-51. PubMed ID: 17390588
[TBL] [Abstract][Full Text] [Related]
13. ACAT2 is localized to hepatocytes and is the major cholesterol-esterifying enzyme in human liver.
Parini P; Davis M; Lada AT; Erickson SK; Wright TL; Gustafsson U; Sahlin S; Einarsson C; Eriksson M; Angelin B; Tomoda H; Omura S; Willingham MC; Rudel LL
Circulation; 2004 Oct; 110(14):2017-23. PubMed ID: 15451793
[TBL] [Abstract][Full Text] [Related]
14. Multiple mechanisms of hypocholesterolemic action of pactimibe, a novel acyl-coenzyme A:cholesterol acyltransferase inhibitor.
Kitayama K; Koga T; Inaba T; Fujioka T
Eur J Pharmacol; 2006 Aug; 543(1-3):123-32. PubMed ID: 16814766
[TBL] [Abstract][Full Text] [Related]
15. Liver-specific inhibition of acyl-coenzyme a:cholesterol acyltransferase 2 with antisense oligonucleotides limits atherosclerosis development in apolipoprotein B100-only low-density lipoprotein receptor-/- mice.
Bell TA; Brown JM; Graham MJ; Lemonidis KM; Crooke RM; Rudel LL
Arterioscler Thromb Vasc Biol; 2006 Aug; 26(8):1814-20. PubMed ID: 16675724
[TBL] [Abstract][Full Text] [Related]
16. Deficiency of acyl CoA:cholesterol acyltransferase 2 prevents atherosclerosis in apolipoprotein E-deficient mice.
Willner EL; Tow B; Buhman KK; Wilson M; Sanan DA; Rudel LL; Farese RV
Proc Natl Acad Sci U S A; 2003 Feb; 100(3):1262-7. PubMed ID: 12538880
[TBL] [Abstract][Full Text] [Related]
17. Lack of phosphatidylethanolamine N-methyltransferase alters plasma VLDL phospholipids and attenuates atherosclerosis in mice.
Zhao Y; Su B; Jacobs RL; Kennedy B; Francis GA; Waddington E; Brosnan JT; Vance JE; Vance DE
Arterioscler Thromb Vasc Biol; 2009 Sep; 29(9):1349-55. PubMed ID: 19520976
[TBL] [Abstract][Full Text] [Related]
18. Cholesterol esters and atherosclerosis-a game of ACAT and mouse.
Rudel LL; Shelness GS
Nat Med; 2000 Dec; 6(12):1313-4. PubMed ID: 11100106
[No Abstract] [Full Text] [Related]
19. Isoform-specific inhibitors of ACATs: recent advances and promising developments.
Ohshiro T; Tomoda H
Future Med Chem; 2011 Dec; 3(16):2039-61. PubMed ID: 22098352
[TBL] [Abstract][Full Text] [Related]
20. Importance of acyl-coenzyme A:cholesterol acyltransferase 1/2 dual inhibition for anti-atherosclerotic potency of pactimibe.
Kitayama K; Tanimoto T; Koga T; Terasaka N; Fujioka T; Inaba T
Eur J Pharmacol; 2006 Jul; 540(1-3):121-30. PubMed ID: 16730694
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
